Back to search

University of Minnesota

Discovery of Small Molecule Inhibitors of Hyaluronan Binding at Cell Receptor CD44

Abstract

dc:description.abstract

Selective inhibitors of hyaluronan (HA) binding to the cell surface receptor CD44 will have value as probes of CD44-mediated signaling, and have potential as therapeutic agents in chronic inflammation, cardiovascular disease and cancer. Using biophysical binding assays, fragment screening, and crystallographic characterization of complexes with the CD44 HA binding domain, we have discovered an inducible pocket adjacent to the HA binding groove into which small molecules may bind. Fragment combination and iterations of structure-driven design has led to identification of a series of 1,2,3,4-tetrahydroisoquinolines as the first non-glycosidic inhibitors of the CD44-HA interaction. The affinity of these molecules for the CD44 HA binding domain parallels their ability to interfere with CD44 binding to polymeric HA in vitro. X-ray crystallographic complexes with lead compounds are described and compared to a new complex with a short HA tetrasaccharide, in order to establish the tetrahydroisoquinoline pharmacophore as an attractive starting point for lead optimization.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Liu, Li-Kai

Subjects

dc:subject × 4

Rights

Language dc:language.iso
en

Identifiers

dc:identifier.*
Dc Identifier Citation
Liu, Li-Kai. (2015). Discovery of Small Molecule Inhibitors of Hyaluronan Binding at Cell Receptor CD44. Retrieved from the University Digital Conservancy, https://hdl.handle.net/11299/182799.

Chain of custody

source
Harvested from
University of Minnesota
Base URL
conservancy.umn.edu/server/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Liu, Li-Kai. Discovery of Small Molecule Inhibitors of Hyaluronan Binding at Cell Receptor CD44. 2015. http://hdl.handle.net/11299/182799